Busy. Please wait.

Forgot Password?

Don't have an account?  Sign up 

show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.

By signing up, I agree to StudyStack's Terms of Service and Privacy Policy.

Already a StudyStack user? Log In

Reset Password
Enter the email address associated with your account, and we'll email you a link to reset your password.

Remove ads
Don't know (0)
Know (0)
remaining cards (0)
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
restart all cards

Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

BBC pharm

ch. 32: Inotropic drugs

this class of drugs combine with sodium potassium ATPase of cardiac cell membrane, inhibiting the Na/K pump. this prevents sodium from being pumped out. as such, sodium levels rise in cardiac cells. xs available Ca released from SR, increasing contractil glycosides.
in the therapeutic index for cardiac glycosides high or low? low, meanng there is a small difference between the therapeutic dose and the toxic dose. regular monitoring of serum drug levels is necessary.
uses of glycosdes? severe left ventricular systolic dysfunction such as CHF
some side effects of glycosides? change in vision (with objects appearing yellow), AV block, arrhythmias (due to decreased intracellulra potassium).
digoxin cannot be used in which patients? those with liver problems as it relies on the liver for its metabolism.
these are beta agonists for the eta one receptor. dobutamine, dopamine
MOA of beta agonsits/ they bind to the receptor, activating adenyl cyclase, which is the enzyme that converts AMP to cAMP. by activating adenylyl cyclase, much AMP is converted to cAMP, which activates protein kinase.
MOA of PDe inhibitors? PDE normally ocnverts cAMP to AMP. PDE inhibitors stop this conversion, resulting in an increase in intracellular calcium.
examples of PDE inhibitors? inamrinone (amrinone), milrinone
all the inotropics have this same final mechanism of action increase the amount of intracellular calcium so thta greater contractility can occur.
what enhances glycoside toxicity? hypokalemia. a common mode of such hypokalemia is through concominant use of thiazide or loop diuretics.
Created by: aferdo01